Non-liver Malignancies as Main Cause of Mortality After HCV Eradication Among People Living With HIV
In our cohort, nonliver-related events and malignancies were the most common cause of death after HCV eradication. Diabetes, ALBI grade ≥2, and AFP ≥3.4 ng/L were associated with higher risk of death. In PLWH after HCV eradication, regardless of liver disease stage, surveillance of nonliver events, particularly malignancies, should be recommended.
Authors
- Diotallevi Sara
- Castagna Antonella
- Uberti-Foppa Caterina
- Galli Laura
- Helmy Hamid
- Alessia Siribelli (ORCID: https://orcid.org/0009-0004-8251-6963)
- Trentacapilli Benedetta.
- Muccini Camilla
- Morsica Giulia
- Lolatto Riccardo
- Bertoni Costanza
- Messina Emanuela
- Bossolasco Simona.
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Janssen (Belgium) (BE)
- Vita-Salute San Raffaele University (IT)
- ViiV Healthcare (Spain) (ES)
- Gilead Sciences (Australia) (AU)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Total Rehab (US)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1097/qai.0000000000003559
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.37